The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Luthi+Webb

AMERICA HOUSE, 35 SHAUL HAMELECH BLVD, PO BOX 33113, TEL AVIV 6492702, ISRAEL
Tel:
Work +972 3 695 2268
Fax:
Fax +972 3 695 1120
Email:
Web:
www.luthi.co.il
Revohot, Tel Aviv

Israel

Intellectual property: disputes
Intellectual property: disputes - ranked: tier 1

Luthi+Webb

Luthi+Webb has experience in complex trade mark and copyright litigation, but is particularly standout in patent disputes, where the team is involved in some of the highest-profile claims in Israel. The team is led by Richard Luthi, who is considered by his peers to be one of the very best IP litigators in the country. Luthi is acting for Millennium Pharmaceuticals (Takeda) in relation to a patent infringement dispute against several Israeli generic drug companies, and also acted for Johnson & Johnson in defence of a patent opposition filed by Teva. In addition, Luthi's team successfully represented Mapi Pharma in a patent opposition filed by Teva regarding Mapi's use of a basic ingredient in Teva's drug, Copaxone. The group is also representing the Knesset, various MPs, and the Speaker of the Knesset in a copyright infringement case initiated by FLASH90, a photojournalism agency. Other key contacts include Martin Binnes, who also has expertise in the pharmaceuticals sector, and Daniel Lerner, who has experience in patent litigation and is engaged by Israel Aerospace Industries and Albemarle Corporation.

Leading individuals

Daniel Lerner - Luthi+Webb

Richard Luthi - Luthi+Webb

[back to top]

Intellectual property: filing/prosecution
Intellectual property: filing and prosecution: patents - ranked: tier 2

Luthi+Webb

Luthi+Webb is the result of a combination of one of the market's leading IP litigation firms and a prosecution firm led by Cynthia Webb. With an advanced chemistry degree and a PhD in immunology, Webb is particularly active in patent prosecution and opposition procedures in the healthcare, pharmaceuticals and life sciences sectors. Key clients in the pharmaceuticals industry include Mapi Pharma and Kamada. Additionally, the team is engaged by a number of research institutions, including Tel Hashomer Medical Research, Hadasit Medical Research Services & Development, Technion Research and Development Foundation, and Yissum Research Development Company.

[back to top]


Further information on Luthi+Webb

Please choose from this list to view details of what we say about Luthi+Webb in other jurisdictions.

Israel

Offices in Tel Aviv and Revohot

Legal Developments in Israel

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • INVESTMENT OPPORTUNITIES FOR HNWIs IN ISRAEL’S HI-TECH ECOSYSTEM

    Accredited investor funding platforms for innovative tech scale-ups offer more choice and without having to commit a large chunk of capital upfront, the risk is diluted.
  • Perhaps the QuadragaCX Story Will Have a Happy Ending

    While there are the aficionados who will say that cryptocurrencies will free us of the chains of the global financial institutions, on the occasions when the world of cryptocurrencies intersects with the world in which most of us live, the news is generally bleak. While you may not know one side of a Bitcoin from the other, you probably know that its value has crashed over the last 13 months, you may even have heard about some of some of the larger cryptohacks (that is computer heists through which digital currencies belonging to investors are stolen from crypto trading exchanges). And over the last week or so, you may have read on mainstream news sites about the death of Gerald Cotton the CEO of Canada’s largest cryptoexchange QuadragaCX. The death of the CEO of a company that few had previously heard of, was news of course, because in his passing he had taken the passwords to the accounts of his customers with him. The result of this being that about $140 million of their money was stuck somewhere between this world and the celestial ether in which Mr. Cotton now resides. Of course, it wasn’t quite told like that. We were fed terms such as “private keys,” lack of “multi-signature protection,” “cold storage wallets” and more readily understandable – “cryptofraud”. Again!
  • Israel Chapter in The Virtual Currency Regulation Review

    Earlier this year, the Israel Tax Authority (ITA) issued two circulars, one on the taxation of digital tokens and the second addressing the taxation of utility tokens in initial coin offerings (ICOs). Additionally, in March, the Israel Securities Authority (ISA) released a detailed interim report by the Committee for the Regulation of Public Offerings of Decentralized Cryptocurrency Coins (Report) (with a follow-up report due to come out around October 2018). Moreover, it is expected that before the end of 2018, legislation will come into force that for the first time will see Israeli primary legislation define virtual currencies as financial assets and mandate licensing for related services, as is later discussed in detail.
  • Spring is coming for real estate registration in Israel

    Israel may be the “Start-up Nation” and a world-renowned center of technological innovation, yet for many years the procedures and conduct of the Israeli Land Registry have been trapped in the past.
  • PLATFORMS FOR HIGH NET WORTH INVESTORS IN ISRAELI HIGH-TECH

    Israeli hi-tech and its sources of funding have grown and diversified tremendously since the bubble burst in 2001 and over the last decade since the height of the financial crisis in 2007-2008.
  • NONDISCRIMINATION IN 5G STANDARDS

    Nondiscrimination has been the neglected stepchild of the FRAND commitment. Patent owners participating in standards organizations typically commit to license their technology on “fair, reasonable, and nondiscriminatory (“FRAND”) terms.”
  • Crash Course on Non-Disclosure Agreements

    Non-disclosure agreements are a crucial, but often overlooked, tool in allowing startup companies to grow, build strategic partnerships and explore new business relationships necessary to develop their product or bring it to market. These agreements are often short (sometimes only a page or two) and lead many founders to forego legal advice to get past this "formality" and begin working with the other party to the NDA. Yet, NDAs are important agreements with potentially far-reaching implications for the protection of a company's confidential information and intellectual property, and mishandling of NDAs can come back to haunt a startup years later.
  • Advocates Eli Greenbaum and Ezra Gross of Yigal Arnon & Co. in The Lawyer Special Report editorial

    An interview-style piece in The Lawyer, Law in Israel: moving beyond tech, quoting Eli Greenbaum and Ezra Gross:
  • Publication of Adv. Adrian Daniel's Commentary in Private Banker International on GDPR & Blockchain

    Publication of Adv. Adrian Daniel's Commentary in Private Banker International on GDPR & Blockchain.
  • Article in MEA Markets on GDPR & Israeli Law

    GDPR & ISRAELI PRIVACY LAW - KEY DIFFERENCES Yoheved Novogroder-Shoshan & Miriam Friedmann of Yigal Arnon & Co. outline the key differences between GDPR & Israeli Privacy Law.  mea_markets_-_gdpr__israeli_law_-_key_differences_14.05.2018